EUVIMEDEUVIMED entdecken
Open Access

Deletion of Interferon Lambda Receptor Elucidates Susceptibility to the Murine Model of Biliary Atresia

Stephen J Hartman iD, Madeleine A Weiss, Haley M Temple, Bryan Donnelly, Rajamouli Pasula, Holly M Poling, Monica McNeal, Sujit K Mohanty, Greg M Tiao

Journal of Interferon & Cytokine Research · 2023

DOI: 10.1089/jir.2023.0046 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Interferon & Cytokine Research, 2023. Verfasst von Stephen J Hartman und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric and Thoracic Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: Biliary Atresia, Cholestasis, Receptors, Interferon. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biliary atresia (BA) is a life-threatening cholangiopathy occurring in infancy, the most common indication for pediatric liver transplantation. The etiology of BA remains unknown; however, a viral etiology has been proposed as multiple viruses have been detected in explants of infants afflicted with BA. In the murine model of BA, Rhesus rotavirus (RRV) infection of newborn BALB/c pups results in a cholangiopathy that mirrors human BA. Infected BALB/c pups experience 100% symptomatology and mortality, while C57BL/6 mice are asymptomatic. Interferon-λ (IFN-λ) is an epithelial cytokine that provides protection against viral infection. We demonstrated that IFN-λ is highly expressed in C57BL/6, leading to reduced RRV replication. RRV-infection of C57BL/6 IFN-λ receptor knockout (C57BL/6 IFN-λR KO) pups resulted in 90% developing obstructive symptoms and 45% mortality with a higher viral titer in bile ducts and profound periportal inflammation compared to C57BL/6. Histology revealed complete biliary obstruction in symptomatic C57BL/6 IFN-λR KO pups, while C57BL/6 ducts were patent. These findings suggest that IFN-λ is critical in preventing RRV replication. Deficiency in IFN-λ permits RRV infection, which triggers the inflammatory cascade causing biliary obstruction. Further IFN-λ study is warranted as it may play an important role in infant susceptibility to BA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biliary AtresiaCholestasisReceptors, InterferonAnimalsMiceDisease Models, AnimalInterferon LambdaInterferonsMice, Inbred C57BL

Stichwörter der Autor:innen

biliary atresiacholangiocytesinterferon-λrhesus rotavirustype III interferon

Substanzen

Interferon LambdaInterferonsReceptors, InterferonIFNLR1 protein, mouse

Autor:innen und Institutionen

  • Department of Pediatric and Thoracic Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Southeast Poultry Research Laboratory, US National Poultry Research Center, United States Department of Agriculture (USDA-ARS), Athens, Georgia, USA.

ORCID-Profile: Stephen J Hartman

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Hartman, S. J., Weiss, M. A., Temple, H. M., Donnelly, B., Pasula, R., Poling, H. M., McNeal, M., Mohanty, S. K., & Tiao, G. M. (2023). Deletion of Interferon Lambda Receptor Elucidates Susceptibility to the Murine Model of Biliary Atresia. Journal of Interferon & Cytokine Research. https://doi.org/10.1089/jir.2023.0046

Vancouver

Hartman SJ, Weiss MA, Temple HM, Donnelly B, Pasula R, Poling HM, et al. Deletion of Interferon Lambda Receptor Elucidates Susceptibility to the Murine Model of Biliary Atresia. Journal of Interferon & Cytokine Research. 2023. doi:10.1089/jir.2023.0046

BibTeX
@article{Hartman2023,
  author = {Hartman, Stephen J and Weiss, Madeleine A and Temple, Haley M and Donnelly, Bryan and Pasula, Rajamouli and Poling, Holly M and McNeal, Monica and Mohanty, Sujit K and Tiao, Greg M},
  title = {Deletion of Interferon Lambda Receptor Elucidates Susceptibility to the Murine Model of Biliary Atresia},
  journal = {Journal of Interferon & Cytokine Research},
  year = {2023},
  doi = {10.1089/jir.2023.0046}
}
Kostenlos starten →